NLRP3 and pemphigus foliaceus: These evidences indicate that NLRP3 inflammasome is involved in the pathogenesis of PF, suggesting that inhibiting EMT process or anti-inflammation by regulating NLRP3 inflammasome is a potential therapeutic strategy for PF.